Most Read Articles
Roshini Claire Anthony, Yesterday

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 5 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
17 May 2018
A study examining the validity of baseline cardiac screening for left ventricular ejection fraction (EF) has found that only two (1.1 percent) of the screened patients have an abnormal EF (<50 percent). These patients have received doxorubicin (anthracycline) chemotherapy despite a compromised EF.
Yesterday
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Thyroglobulin antibodies common in paediatric thyroid cancer

16 Sep 2017

Circulating thyroglobulin antibodies (TgAb) are not infrequent at diagnosis in children with thyroid cancer, but these resolve within a year or two in almost half of patients, according to a recent study. Furthermore, TgAb is associated with the presence of lymph node metastasis at diagnosis, but the long-term prognostic significance remains to be known.

Researchers conducted a retrospective cohort study in a single academic paediatric centre to examine the prevalence, natural history and clinical significance of TgAb in children with nonmedullary thyroid cancer. A total of 73 consecutive patients who had serum TgAb measured within 6 months after diagnosis were included.

There were 30 children (41 percent) diagnosed with TgAb, which also correlated with lymph node metastasis (83 vs 53 percent; p=0.01) but not distant metastasis.

At a median follow-up of 3.8 years, resolution occurred in 11 (44 percent) of 25 patients with TgAb, with a median time to clear TgAb of 10.7 months. Ten (91 percent) of these participants who cleared did so within 2 years. Resolution of TgAb correlated with lower initial TgAb level (median 4.5 vs 76 normalized units; p=0.003).

There was no independent association observed between TgAb positivity at diagnosis and persistent or recurrent disease (odds ratio, 3.20; 95 percent CI, 0.95 to 10.80; p=0.06).

These findings are consistent with those of an earlier study. Xu and colleagues said that TgAb are common in patients with thyroid cancer but resolve after treatment at about ‒11 percent IU/mL per month from preoperative levels with median resolution at 11.0 months. Furthermore, persistently elevated levels after thyroidectomy did not correlate with disease recurrence in their series. [J Surg Res 2015;198:366-70]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, Yesterday

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 5 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
17 May 2018
A study examining the validity of baseline cardiac screening for left ventricular ejection fraction (EF) has found that only two (1.1 percent) of the screened patients have an abnormal EF (<50 percent). These patients have received doxorubicin (anthracycline) chemotherapy despite a compromised EF.
Yesterday
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.